n-3 polyunsaturated fatty acids in milk is associate to weight gain and growth in premature infants by Tinoco, Sandra M Barboza et al.
BioMed  Central
Page 1 of 10
(page number not for citation purposes)
Lipids in Health and Disease
Open Access Research
n-3 polyunsaturated fatty acids in milk is associate to weight gain 
and growth in premature infants
Sandra M Barboza Tinoco1, Rosely Sichieri2, Cecília L Setta3, Anibal S Moura1 
and Maria G Tavares do Carmo*3
Address: 1Departamento de Ciências Fisiológicas/Laboratório de Fisiologia Celular da Universidade do Estado do Rio de Janeiro, Rio de Janeiro, 
Brazil, 2Instituto de Medicina Social, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil and 3Instituto de Nutrição Josué de Castro, 
Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
Email: Sandra M Barboza Tinoco - sandramtinoco@gmail.com; Rosely Sichieri - sichieri@ims.uerj.br; 
Cecília L Setta - sandramtinoco@gmail.com; Anibal S Moura - asmoura@uerj.br; Maria G Tavares do Carmo* - tcarmo@editema.com.br
* Corresponding author    
Abstract
Background: Linoleic 18:2 (n-6) and α-linolenic 18:3 (n-3) essential fatty acids and long-chain
polyunsaturated fatty acids (LC-PUFA) are essential nutrients for growth and neonatal
development. Consumption of preformed n-3 LC-PUFA has been shown to increase gestational
duration and to decrease the incidence of premature birth in human studies. This study evaluated
the association of essential fatty acids and LC-PUFA in breast milk on the growth of premature
children (weight, height and head circumference).
Study design: Thirty-seven premature infants with a gestational age of 37 weeks or less were
followed until 6 months of gestational age, adjusted for prematurity. The milk from mothers,
weight, height and head circumference measures of children were collected during the follow up.
The breast milk fatty acids were quantified by gas-liquid chromatography.
Results: Our results showed that total n-3 PUFA was positively associated with weight gain (p =
0.05), height (p = 0.04) and body mass index (BMI) of children (p = 0.05). Our results also indicate
that both linoleic acid and total essential fatty acids were positively associated with BMI and head
circumference, whereas oleic acid was positively associated only with head circumference.
Conclusion: These results suggest that the n-3 PUFA composition of milk may be associated with
weight gain and growth. Considering the advantages of n-3 LC-PUFA consumption on infant growth
and visual function and its association with reduced incidence of premature birth, dietitians should
advise pregnant women to increase their intake of foods high in n-3 LC-PUFA.
Introduction
The n-3 polyunsaturated fatty acids, also known as omega
3 fatty acids, are fatty acids with the first double bound at
the third position from the methyl end. They occur in the
diet as α-linolenic acid (ALA, C18:3n-3) from vegetable
sources and nuts, and as very-long-chain 'marine' n-3 pol-
yunsaturated fatty acid (LC-PUFA) from fish and othern
seafood. The main forms of marine n-3 LC-PUFA are
eicosapentaenoic acid (EPA, C20:5 n-3) and docosahexae-
noic acid (DHA, C22:6 n-3) [1]. Typical intake in Western
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populations is 1–2 g per day for ALA and 0–0.4 g per day
for marine n-3 LC-PUFA [2]. The importance of ALA as a
dietetic precursor to EPA and DHA in the human body has
also been reported [3]; however, various studies have indi-
cated that the conversion of ALA to functional forms of n-
3 LC-PUFA, such as DHA and EPA, is not adequate human
beings [2,4,5]. Because the placenta lacks desaturase activ-
ity and fetal enzyme activity in uterus is very limited, the
fetus depends on placental LC-PUFA transfer [6].
Over the past few decades, n-3 LC-PUFAs have been
shown to be essential for neurodevelopment [7-10]. These
essential fatty acids, including DHA, α-linolenic acid, and
other fatty acids of the n-3 series, are indispensable struc-
tural components of cellular membranes and are essential
for cerebral and retinal growth, especially in the first two
years after birth [11-13]. The deposition of DHA in the ret-
ina and in the cerebral cortex occur especially during the
third trimester of gestation and in the first six months of
extrauterine life; therefore, both the last three months of
gestation and first few months after birth are particularly
vulnerable to developmental deficits, if DHA is limiting
[10,14].
The premature babies, in particular, born during the last
trimester of pregnancy have been shown to have low lev-
els of DHA in the blood; this has been correlated with
their abnormal eye and brain functions as measured by
electroretinogram, cortical visual-evoked potential, and
behavioral testing of visual acuity [15,16]
In the other hand, consumption of preformed n-3 LC-
PUFA has been shown to increase the duration of gesta-
tion and to decrease the incidence of premature birth in
both human and animal studies [2,17]. Thus, n-3 defi-
ciency may enhance the risk of premature delivery. There-
fore, adequate supplementation of n-3 LC-PUFA becomes
essential during the prenatal period and is especially
important for pre-mature children [18,19]. The premature
baby may be particularly at risk for deficiency of essential
long chain fatty acids for the following reasons: 1)
neonates and pre-mature children have less adipose tis-
sue, and are therefore more prone to fatty acid deficiencies
[13,20]; 2) LC-PUFAs are deposited in considerable quan-
tities during the last trimester of gestation for the growth
of the brain and the retina, and premature children are
not born with these deposits [3,14]; and 3) the metabo-
lism of the fatty acids in premature infants is still imma-
ture. The LC-PUFAS, DHA and AA can be synthesized
from ALA and LA, although the activity of conversion is
low in humans [2,4,5]. The extent of this conversion of
ALA in premature children is not precisely known and is,
at best, very limited. [3,6,21]
Although many studies have shown that n-3 LC-PUFAs
are beneficial to infant development, the effects of mater-
nal levels of these essential fatty acids on the growth of
premature infants are not completely understood. Studies
investigating the association of n-3 PUFAs in human milk
are scarce. The objective of this study is to investigate asso-
ciations between human milk levels of n-3 LC-PUFA,
including essential fatty acids and long chain polyunsatu-
rated fatty acids, and the growth of premature children.
Materials and methods
Process of Selecting the Population
Male and female children born prematurely (gestational
age less than 37 weeks) in the Department of Neonatol-
ogy of the Institute Fernandes Figueira – IFF/FIOCRUZ,
Rio de Janeiro, Brazil were selected for this study The
study was initiated only after written consent of the parent
or guardian, and parents were fully informed of the study
goals, methods, risks, and benefits before consent was
obtained. Both the project and the consent form were
approved by the Ethics Committee for Research in
Humans of the Institute Fernandes Figueira/Oswaldo
Cruz Foundation (IFF/FIOCRUZ, Rio de Janeiro, Brazil)
before the study began and its conduction was in accord-
ance with the Declaration of Helsinki. The children under-
went ambulatory monitoring until they reached six
months of corrected gestational age for prematurity (age
of birth in gestational weeks less than 40 weeks–where the
gravidic cycle is complete; full pregnancy).
The gestational age (GA) was determined from the infor-
mation collected from the mothers or, in cases where the
information was not precise, an estimate of the GA was
made. This estimate was based on the date of the last men-
strual period (LMP), which was either reported by the
mother or identified by ultrasound at the 20th week of
gestation. In cases where there was a lack of information,
we evaluated the GA by using the method of New Ballard
[22].
Initially, 215 premature children were selected. Of these,
47 were excluded because they presented a form of
pathology (carriers of syndromes or genetic birth defects,
alterations in the gastrointestinal tract or the respiratory
tract, renal dysfunction, neurological disorders, the pres-
ence of congenital infections such as rubella, citomegalia,
toxoplasmosis, and herpes, or children of mothers carry-
ing the HIV virus), or because they were receiving artificial
milk. In the first month of follow-up, there were 3 deaths
and 12 losses due to mothers who never returned for the
follow-up of their baby. Of the 153 premature children,
50 had no collection of milk at birth (colostrum) because
the mothers had initial difficulties in the collection of
milk due to the following reasons: refusal (did not coop-
erate with the study), had no milk before hospital dis-Lipids in Health and Disease 2009, 8:23 http://www.lipidworld.com/content/8/1/23
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charge, were already drawing milk for the milk bank,
declined due to pain, or did not schedule a time to meet
with the researcher upon their return visit to the hospital
during the first few days after delivery. Of the 103 children
for whom their mother's milk was collected, 38 had milk
collected at baseline only (colostrum), and 65 children
had milk collected at baseline (colostrum) as well as in
the follow-up period. Thus, the study population includes
65 children who were breastfed for at least 1 month of fol-
low-up. Of these 65 children, 37 were randomly selected
for analysis of fatty acids in the maternal milk.
For a type I error of 0.05 and a type II error of 0.20 with a
standard deviation of 1 unit and a difference of 1 unit, the
required sample size would be 32 children. Therefore, for
the estimated number of 37 children, it is possible to
observe changes to the standard deviations up to 1.53
units at baseline when the samples are independent.
Collection of Data
The weight, height, and head circumference were
obtained by anthropometry once a month at the outpa-
tient visit. The body weight of premature infants was
measured in a calibrated digital balance (Fillizola) when
the babies were naked. Their length was measured by plac-
ing the premature infants in a horizontal decubitus, where
they were measured from the crown to the heel. The head
circumference was obtained by using an measuring tape at
the supra-orbital ridges and at the largest frontoccipital
diameter.
The nursing team collected the breast milk during the
monthly outpatient visit. One milliliter of milk was col-
lected from each mother and then deposited in identified
ependorffs. The milk samples were frozen at -70°C for
later analysis.
Fatty acid analysis
The fatty acids in the breast milk were evaluated by gas
chromatography. The extraction, saponification and lipid
methylation were performed in duplicate from 200 μl of
milk, according to the method of Lepage and Roy [23],
which recommends treatment with 2 ml methanol: tolu-
ene 4:1 (v/v) solution and 200 μl of acetyl chloride added
under light agitation. The methyl esters were quantified by
gas-liquid chromatography using a Perkin Elmer Autosys-
tem XL chromatograph equipped with an ionized flame
detector (FID) and a software turbochrom. The fatty acids
were separated on a 100 × 0.25 mm × 0.20 μm capillary
column SP 2560 (Supelco, USA). The gas chromato-
graphic conditions were the same as those described else-
where [24] The esters were identified by comparison with
their retention time with known standards (Sigma,
Supelco). The results were expressed as the percentage of
total fatty acids.
Statistical analysis
The selected premature infants were analyzed for changes
in body weight, height and head circumference, and these
data were correlated with the concentrations of various
fatty acids in milk that could be related to growth. The
chromatographic analysis was performed on the milk col-
lected from their mothers shortly after delivery (colos-
trum), and a second assessment of milk was collected
between post-partum days 35 and 42 from the mother of
the same child (mature milk).
The databases were constructed using software EPI INFO
[25]. The follow-up data from the cohort of premature
infants were analyzed using the proc mixed procedure of
the SAS statistical package (Statistic Analysis System), ver-
sion 8.0 (SAS Institute, Cary, NC, USA) [26,27].
For each one of the outcomes: weight, height, body mass
index (BMI) and head circumference, regression models
included as independent variables the difference between
mature milk – colostrum of fatty acids, time and an inter-
action factor (differences in fatty acids * time). Therefore,
if BMI increased during follow-up and this change was
related to fatty acids the variable both time and the inter-
action factor will be statistically significant.
The difference of values of fatty acids for the two collec-
tion times for milk (mature milk and colostrum) was cat-
egorized in below the median and above the median
allowing plotting two curves for comparisons as in the fig-
ures 1 and 2. The difference of values of fatty acids for the
two time points is positive when the value for mature milk
was higher than that of colostrum, so values above the
median also represent increasing levels of fatty acids and
vice versa.
Results
Table 1 shows the anthropometric measures according to
the time of follow-up, initiated at birth (0) and up to six
months (1 to 6) of life. The nutritional assessment data
indicate that female children had an average birth weight
of 1790 g and an average height of 43 cm. The average
male height and weight at birth were 44.8 cm and 2135 g,
respectively. Values of head circumference are also pre-
sented in Table 1, but these measures were not registered
at birth or during the first month of life. All children
exceeded the 2500 g recommended by WHO/OMS at two
months of life.
The differences between the fatty acids for the two collec-
tion times for milk (mature milk and colostrum) were
evaluated in relation to anthropometric variables in the
multivariate regression analysis. Gestational age and birth
weight, variables known to influence growth, were ini-
tially included in the models, but because they did notLipids in Health and Disease 2009, 8:23 http://www.lipidworld.com/content/8/1/23
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Estimated values for body mass index (Kg/m2) (BMI) Figure 1
Estimated values for body mass index (Kg/m2) (BMI). Model included the difference of linoleic fatty acid (A), and total 
essential fatty acid (B) between of mature milk and colostrum, time of follow-up (time) and the interaction difference of fatty 
acids *time. A – linoleic fatty acid. B – total essential fatty acid.
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Estimated values for head circumference (cm) Figure 2
Estimated values for head circumference (cm). Model included the difference of linoleic fatty acid (A), and total essential 
fatty acid (B), oleic fatty acid (C) between of mature milk and colostrum, time of follow-up (time) and the interaction difference 
of fatty acids *time. A – linoleic fatty acid. B – total essential fatty acid. C – oleic fatty acid.
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change the associations of fatty acids and growth they
were excluded. Therefore, the models that are presented in
Tables 2, 3, 4 and 5 include only the fatty acid differences,
time and the interaction between time and the fatty acids.
The regression coefficient (β) for weight in grams (g) indi-
cated variations positive over time, which was statistically
significant for all fatty acids. The total n-3 PUFA was pos-
itively associated with weight gain (p = 0.05). The variable
of interaction between time and the fatty acid difference
estimates the rate of change of weight in relation to differ-
ent fatty acids, was statistically significant and negative for
acid DHA, linoleic, total LC-PUFA, and total essential fatty
acids (Table 2).
Table 3 shows estimated values of the coefficients of the
fatty acid variables for height in centimeters (cm). Based
on these figures, we observed that the total n-3 PUFA was
positively associated with a gain in height (p = 0.04). The
rate of change of growth (difference of fatty acid*time), in
relation to all fatty acids was not statistically significant.
Our results showed a positive and statistically significant
association (p = 0.05) of total n-3-PUFA with BMI. The
rate of change of body mass index (BMI) was negative and
statistically significant for the DHA, linoleic acid, total LC-
PUFA and total essential fatty acids. (Table 4).
Table 1: Number of observations (N), means and standard deviation (SD) of weight, height and head circumference of premature 
children, by sex and follow-up time.
Weight (g) Height (cm) Head circumference (cm)
Time (months) N Mean SD N Mean SD N Mean SD
Male
0 21 2135 354 21 44.8 3.80 - - -
1 21 3031 1154 21 49.6 4.10 - - -
2 19 4434 1286 19 54.3 4.45 17 37.2 2.18
3 19 5566 1457 19 59.6 5.14 16 39.4 2.38
4 15 6449 1715 15 63.3 6.66 15 41.6 2.95
5 12 6545 1232 12 64.0 4.09 10 41.7 1.70
6 11 7183 1407 10 66.5 5.08 10 42.9 1.86
Female
0 16 1790 482 16 43.0 4.32 - - -
1 16 2527 542 16 47.1 3.09 - - -
2 16 4348 947 16 54.8 4.35 16 37.5 2.12
3 16 5260 966 16 58.9 4.21 15 38.9 2.15
4 16 6040 1056 16 62.2 4.33 15 40.1 1.79
5 15 6694 1149 15 65.1 3.52 13 40.8 1.69
6 9 6945 1153 8 67.1 3.31 7 42.1 1.86
Table 2: Regression coefficient (β) and p-value of the variables included in the regression model for WEIGHT in grams (g)
Fatty acids Difference of fatty acids Time* (months) Difference of fatty acids*time
β P ββ P
Total transa - 413.14 0.20 763.02 5.04 0.92
Total saturatedb 138.57 0.67 690.70 45.52 0.37
C18:1 n-9 (Oleic) 225.92 0.49 854.56 -65.90 0.19
C18:3 n-3 (α-Linolenic) 565.85 0.07 762.44 -4.50 0.93
C18:2 n-6 (Linoleic) 213.77 0.52 930.34 -114.12 0.02
Total essentialsc 213.77 0.52 930.34 -114.12 0.02
C20:5 n-3 (EPA) -83.49 0.80 715.28 25.89 0.61
C22:6 n-3 (DHA) 364.97 0.27 944.33 -127.18 0.01
C20:4 n-6 (ARA) -134.04 0.68 845.94 -62.39 0.22
Total LC-PUFAd 302.32 0.35 898.21 -101.98 0.04
Total n-3 PUFAe 615.18 0.05 791.39 -24.87 0.63
Total n-6 PUFAf 175.32 0.60 860.17 -67.66 0.18
*P-values < 0.0001 for all fatty acids. a Includes all isomers of C18:1; b includes C14:0, C15:0, C16:0 and C18:0; c includes C18:3 n-3 and C18:2 n-6; 
d includes EPA (eicosapentaenoic fatty acid), DHA (docosahexaenoic fatty acid) and ARA (arachidonic fatty acid); e includes C18:3 n-3, C20:5 n-3, 
C22:5 n-3 and C22:6 n-3; f includes C18:2 n-6, C18:3 n-6, C20:2 n-6, C20:3 n-6, C20:4 n-6 and C22:4 n-6. PUFA, polyunsaturated fatty acid.Lipids in Health and Disease 2009, 8:23 http://www.lipidworld.com/content/8/1/23
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The estimated values of the coefficients for head circum-
ference are in Table 5. The rate of change of the head cir-
cumference was statistically significant in relation to oleic
acid, total saturated fatty acid, EPA, total n-3 PUFA, lino-
leic acid, total n-6 PUFA and total essential fatty acid.
(Table 5).
The estimated values of BMI for values above and bellow
the differences in fatty acids based on the regression
model which included also time of follow-up and the
interaction variable between time and categorized value
for the difference of fatty acids are represented in Figures
1 for linoleic acid (Figure 1A), that shows that the smaller
reduction in milk of linoleic acid levels was associated
with greater increase in BMI. Figure 1B shows the estimate
change in BMI according to the variation for total essential
fatty acids (α-linolenic and linoleic). The estimated
parameters are in Table 4.
Figures 2 shows the estimated values for head circumfer-
ence, which estimated parameters are in Table 5. We
observed that the smaller reduction in milk of linoleic
acid levels, the greater the increase in head circumference
at follow-up (Figure 2A). In Figures 2B and 2C indicates
that there is a greater head circumference increase in chil-
dren at the follow-up when there is a smaller reduction in
the levels of total essential fatty acids (α-linolenic and
linoleic) and oleic acid levels in milk.
Discussion
In this study, we analyzed the effect of fatty acids on
anthropometric variables in premature infants, where the
results showed that the total amount of n-3 PUFA found
Table 3: Regression coefficient (β) and p-value of the variables included in the regression model for HEIGHT in centimeters (cm)
Fatty acids Difference of fatty acids Time* (months) Difference of fatty acids*time
β P ββ P
Total transa -1.80 0.10 3.22 0.02 0.92
Total saturatedb -0.40 0.73 2.84 0.30 0.12
C18:1 n-9 (Oleic) 0.88 0.43 3.54 -0.19 0.31
C18:3 n-3 (α-Linolenic) 2.02 0.06 3.33 -0.05 0.78
C18:2 n-6 (Linoleic) 0.98 0.39 3.70 -0.29 0.13
Total essentialsc 0.98 0.40 3.70 -0.29 0.13
C20:5 n-3 (EPA) -0.14 0.90 2.97 0.19 0.33
C22:6 n-3 (DHA) 1.10 0.33 3.65 -0.27 0.16
C20:4 n-6 (ARA) -0.75 0.50 3.39 -0.10 0.61
Total LC-PUFAd 1.15 0.30 3.72 -0.33 0.09
Total n-3 PUFAe 2.30 0.04 3.48 -0.15 0.43
Total n-6 PUFAf 0.78 0.49 3.40 -0.10 0.61
*P-values < 0.0001 for all fatty acids. aIncludes all isomers of C18:1; b includes C14:0, C15:0, C16:0 and C18:0; c includes C18:3 n-3 and C18:2 n-6; d 
includes EPA (eicosapentaenoic fatty acid), DHA (docosahexaenoic fatty acid) and ARA (arachidonic fatty acid); e includes C18:3 n-3, C20:5 n-3, 
C22:5 n-3 and C22:6 n-3; f includes C18:2 n-6, C18:3 n-6, C20:2 n-6, C20:3 n-6, C20:4 n-6 and C22:4 n-6. PUFA, polyunsaturated fatty acid.
Table 4: Regression coefficient (β) and p-value of the variables included in the regression model for BMI (kg/m2)
Fatty acids Difference of fatty acids Time* (months) Difference of fatty acids*time
β p ββ P
Total transa -0.45 0.42 0.68 0.002 0.99
Total saturatedb 0.48 0.38 0.51 0.13 0.27
C18:1 n-9 (Oleic) 0.13 0.81 0.81 -0.09 0.45
C18:3 n-3 (α-Linolenic) 0.96 0.08 0.77 -0.05 0.64
C18:2 n-6 (Linoleic) 0.21 0.72 1.12 -0.28 0.02
Total essentialsc 0.21 0.72 1.12 -0.28 0.02
C20:5 n-3 (EPA) -0.34 0.54 0.54 0.10 0.40
C22:6 n-3 (DHA) 0.76 0.18 1.01 -0.22 0.05
C20:4 n-6 (ARA) 0.16 0.78 0.98 -0.19 0.09
Total LC-PUFAd 0.80 0.15 1.09 -0.28 0.01
Total n-3 PUFAe 1.06 0.05 0.82 -0.09 0.43
Total n-6 PUFAf 0.04 0.94 0.93 -0.16 0.17
*P-values < 0.03 for all fatty acids. a Includes all of isomers of C18:1; b includes C14:0, C15:0, C16:0 and C18:0; c includes C18:3 n-3 and C18:2 n-6; 
d includes EPA (eicosapentaenoic fatty acid), DHA (docosahexaenoic fatty acid) and ARA (arachidonic fatty acid); e includes C18:3 n-3, C20:5 n-3, 
C22:5 n-3 and C22:6 n-3; f includes C18:2 n-6, C18:3 n-6, C20:2 n-6, C20:3 n-6, C20:4 n-6 and C22:4 n-6. PUFA, polyunsaturated fatty acid.Lipids in Health and Disease 2009, 8:23 http://www.lipidworld.com/content/8/1/23
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in mother's milk was positively associated with weight
gain (p = 0.05), gain of height (p = 0.04) and BMI of pre-
mature children (p = 0.05) (Table 2, 3 and 4). These data
confirm the importance of n-3 PUFA in the development
and growth of premature children.
In fact, the n-3 PUFA, including DHA, α-linolenic acid
and other fatty acids of the n-3 series, are essential struc-
tural components for cell membranes and are important
for the growth of the brain and retina, especially in the
first two years after birth [12,13]. However, an important
aspect to be emphasized in the results of this study was the
influence of these n-3 PUFAs not only on weight, but also
on height and, consequently, on the BMI in the first
months of life of a premature child. This effect can be
explained by the fact that n-3 PUFAs are mainly involved
in cell growth and multiplication [13], thus exerting a pos-
itive effect on weight and height of children. Olsen et al.
[28] also demonstrated an association between increased
consumption of dietary n-3 PUFA by pregnant women
with increasing birth weight of their children. A study
involving 8,729 pregnant Danish women found that low
fish consumption was a strong risk factor for preterm
delivery and low birth weight [29]. Therefore, there is a
need for greater maternal intake of n-3 PUFAs during the
intra-uterine phase and during the first months of an
infant's life [10] because the mother has the fundamental
role in the transfer of these fatty acids through the pla-
centa and breast milk [19]. Because n-3 PUFA can influ-
ence a wide variety of biological functions, including
being essential for the growth and function of the human
body, it is important that expectant mothers meet the
nutritional recommendations for the consumption these
fatty acids in their diets [19].
Because of the inherent problems with assessing diet and
maintaining appropriate food composition tables, many
investigators are now assessing dietary intake of PUFAs
using biomarkers; in general, the concentrations of PUFAs
in breast milk reflect the maternal intake of the previous
day [30]. Innis [31] found a positive correlation between
the content of DHA in milk with visual and language
development in breast-fed infants, while a recent Norwe-
gian study found that children of mothers who received
supplementation with cod liver oil during pregnancy had
an improved mental processing score at four years of age
[16]. Assessing the n-3 PUFA levels in the milk of mothers
of premature babies, we observed that there was no signif-
icant variation in the total amount of n-3 PUFA found in
the colostrum compared to mature milk. We hypothe-
sized that the presence of n-3 PUFA in milk may be asso-
ciated with weight gain and structural development in
children.
Although the rate of change in BMI was negative in rela-
tion to linoleic acid and total essential fatty acids, our
results indicate that both linoleic acid and total essential
fatty acid are associated with increased BMI in premature
children. In the model adjusted by time of follow-up and
the interaction variable between time and categorized
value for the difference of fatty acids (difference of fatty
acids*time), it can be seen that the smaller reductions in
the linoleic acid levels (Figure 1A) and total essential fatty
acid (Figure 1B), the greater the increase in BMI during the
follow-up period. Similar results were observed for head
circumference in relation to linoleic acid, total essential
fatty acid and oleic acid (Table 5); the higher the levels of
linoleic acid (Figure 2A), oleic acid (Figure 2C) and total
essential fatty acids (Figure 2B) in milk, the greater the
increase in head circumference during the follow-up.
Table 5: Regression coefficient (β) and p-value of the variables included in the regression model for HEAD CIRCUMFERENCE in 
centimeters (cm)
Fatty acids Difference of fatty acids Time* (months) Difference of fatty acids*time
β p ββ p
Total transa -0.97 0.15 1.22 -0.03 0.74
Total saturatedb 0.26 0.71 0.94 0.16 0.05
C18:1 n-9 (Oleic) 0.84 0.23 1.48 -0.21 0.008
C18:3 n-3 (α-Linolenic) 1.11 0.08 0.98 1.14 0.09
C18:2 n-6 (Linoleic) 1.01 0.16 1.60 -0.27 0.0005
Total essentialsc 1.01 0.16 1.60 -0.27 0.0005
C20:5 n-3 (EPA) -0.22 0.75 0.91 0.17 0.03
C22:6 n-3 (DHA) 0.70 0.31 1.24 -0.04 0.60
C20:4 n-6 (ARA) -0.48 0.49 1.06 0.07 0.37
Total LC-PUFAd 0.36 0.61 1.18 -0.006 0.95
Total n-3 PUFAe 0.92 0.16 0.93 0.17 0.04
Total n-6 PUFAf 0.61 0.39 1.46 -0.19 0.02
*P-values < 0.0001 for all fatty acids. a Includes all of isomers of C18:1; b includes C14:0, C15:0, C16:0 and C18:0; c includes C18:3 n-3 and C18:2 n-
6; d includes EPA (eicosapentaenoic fatty acid), DHA (docosahexaenoic fatty acid) and ARA (arachidonic fatty acid); e includes C18:3 n-3, C20:5 n-3, 
C22:5 n-3 and C22:6 n-3; f includes C18:2 n-6, C18:3 n-6, C20:2 n-6, C20:3 n-6, C20:4 n-6 and C22:4 n-6. PUFA, polyunsaturated fatty acid.Lipids in Health and Disease 2009, 8:23 http://www.lipidworld.com/content/8/1/23
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Within the diversity of fatty acids, we can say that not only
the LC-PUFAs, but also their metabolic precursors, the
essential fatty acids (linoleic and linolenic), are trans-
ferred through breast milk to the child and may also exert
a positive effect on the health of the child by encouraging
early brain development and growth, as was reflected by
the increase in BMI. Essential fatty acids also have an
important role during the intra-uterine phase, extending
the length of gestation and thereby influencing birth
weight [3]. The unquestionable necessity of essential fatty
acids is demonstrated by these results, so the type of acid
that accumulates in fetal tissue can determine weight gain,
height gain and increases in head circumference.
In summary, this study demonstrates the influence of
maternal lipid consumption during lactation or breast-
feeding in the growth of premature infants. It is clear that
dietary polyunsaturated fatty acids are transferred into
human breast milk and, subsequently, to the child. The
results of this study point to the influence of maternal
nutrition during pregnancy and lactation on infant
growth in the first months of life, reinforcing the need for
maternal nutritional education about appropriate con-
sumption of n-3 PUFA and essential fatty acids to support
healthy infant growth [9].
In conclusion, we found that the quality of dietary lipids
offered through breast milk during the first months of life
is a critically important determinant in the of growth pre-
mature infants.
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